AstraZeneca Joins Big Pharma's Offensive On Price Talks
AstraZeneca joined a chorus of pharmaceutical companies and other parties in challenging the Inflation Reduction Act's provision allowing Medicare to negotiate drug prices with drugmakers....To view the full article, register now.
Already a subscriber? Click here to view full article